Blueprint Medicines Corporation (BPMC) Social Stream



Blueprint Medicines Corporation (BPMC): $57.75

3.47 (+6.39%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add BPMC to Watchlist
Sign Up

Industry: Biotech


Ranked

of 373

in industry

BLUEPRINT MEDICINES CORP (BPMC) Price Targets From Analysts

Use the tables below to see what analysts covering BLUEPRINT MEDICINES CORP think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 9 $136 $84 $113.222 $54.28 108.59%
2021-11-10 9 $136 $84 $114.444 $54.28 110.84%
2021-11-19 9 $136 $84 $115.777 $54.28 113.3%
2021-11-29 9 $136 $84 $115.555 $54.28 112.89%
2022-01-12 9 $135 $84 $113.333 $54.28 108.79%
2022-01-25 9 $135 $84 $110.555 $54.28 103.68%
2022-01-31 9 $135 $84 $108.444 $54.28 99.79%
2022-02-08 9 $135 $84 $104.777 $54.28 93.03%
2022-02-17 9 $133 $82 $100.625 $54.28 85.38%
2022-03-01 10 $133 $71 $97.333 $54.28 79.32%
2022-04-12 10 $133 $71 $97.888 $54.28 80.34%
2022-04-28 10 $133 $68 $97.555 $54.28 79.73%
2022-05-04 10 $133 $68 $96.7 $54.28 78.15%
2022-05-18 10 $152 $65 $100.272 $54.28 84.73%
2022-06-01 10 $152 $65 $99.363 $54.28 83.06%
2022-06-10 10 $152 $41 $96.909 $54.28 78.54%
2022-06-14 10 $152 $41 $92.454 $54.28 70.33%
2022-07-27 12 $152 $40 $86.461 $54.28 59.29%
2022-08-02 10 $152 $40 $86.461 $54.28 59.29%
2022-08-03 13 $152 $40 $89.642 $54.28 65.15%
2022-08-17 13 $152 $40 $88.214 $54.28 62.52%
2022-08-18 13 $152 $40 $87.285 $54.28 60.81%
2022-08-22 13 $152 $40 $87.714 $54.28 61.6%
2022-09-06 13 $152 $40 $88.428 $54.28 62.91%
2022-10-10 14 $152 $40 $89.533 $54.28 64.95%
2022-10-26 14 $152 $40 $89.8 $54.28 65.44%
2022-11-02 15 $152 $40 $85.133 $54.28 56.84%
2022-11-04 16 $115 $40 $78.733 $54.28 45.05%
2022-12-12 16 $115 $40 $78.4 $54.28 44.44%
2022-12-14 17 $115 $40 $77.25 $54.28 42.32%
2022-12-20 17 $115 $40 $77.437 $54.28 42.66%
2023-01-23 17 $115 $41 $77.5 $54.28 42.78%
2023-02-06 17 $115 $41 $75.375 $54.28 38.86%
2023-02-10 17 $115 $41 $75.062 $54.28 38.29%
2023-02-14 17 $115 $41 $74.625 $54.28 37.48%
2023-02-17 17 $115 $41 $72.125 $54.28 32.88%
2023-02-23 17 $114 $41 $69.875 $54.28 28.73%
2023-02-27 17 $114 $38 $69.25 $54.28 27.58%
2023-02-28 17 $114 $38 $69.25 $54.28 27.58%
2023-03-28 17 $114 $38 $69.5 $54.28 28.04%
2023-04-25 17 $114 $38 $69.5 $54.28 28.04%
2023-05-05 17 $114 $41 $70.2 $54.28 29.33%
2023-05-23 18 $114 $41 $72.437 $54.28 33.45%

The Trend in the Analyst Price Target


Over the past 36 months, BPMC's average price target has gone down $18.51.

BPMC reports an average of 57.67% for its upside potential over the past 51 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-08-18 13 152 40 87.285 64.09 36.19%
2022-12-14 17 115 40 77.250 46.73 65.31%
2023-01-23 17 115 41 76.937 46.51 65.42%
2023-02-28 17 114 38 69.250 42.37 63.44%
2023-03-28 17 114 38 69.500 42.57 63.26%

BPMC Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.94 10 1 6 1 1 18

The Trend in the Broker Recommendations


BPMC's average broker recommendation rating improved by 0.26 over the prior 26 weeks.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • BPMC has a lower variance in analysts' estimates than -3942.19% of all US stocks.
  • In the context of stocks in the mid market cap category, BLUEPRINT MEDICINES CORP's number of analysts covering the stock is greater than 4275.24% of them.
  • BLUEPRINT MEDICINES CORP's average analyst price target is higher than 4150.48% of Pharmaceutical Products stocks.
  • BLUEPRINT MEDICINES CORP's upside potential (average analyst target price relative to current price) is higher than 1582.78% of Pharmaceutical Products stocks.

In the Pharmaceutical Products industry, MCRB, ASND, and QURE are the three stocks most similar to BLUEPRINT MEDICINES CORP regarding the price target and analyst recommendation information presented here.

Is BPMC a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7568 seconds.